NCT00805701View on ClinicalTrials.gov

Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantation

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Prostate Cancer
Interventions
DRUG

avodart

0.5 avodart once daily for 13 weeks

DRUG

Placebo

placebo

Trial Locations (1)

02472

Bay State Clinical Trials, Inc., Watertown

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Bay State Clinical Trials, Inc.

OTHER

NCT00805701 - Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantation | Biotech Hunter | Biotech Hunter